img

Companion Diagnostic Tests in Oncology


Published on: 2024-01-04 | No of Pages : 178 | Industry : Pharma & Healthcare

Publisher : MRA Reports | Format : PDF&Excel

Companion Diagnostic Tests in Oncology

The global Companion Diagnostic Tests in Oncology market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on MRA Reports newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).



By Market Verdors

Abbott

Roche

Genomic Health

QIAGEN

Agilent

Agendia

BioMerieux

Illumina

Siemens Healthcare

Thermo Fisher



By Types

Protein Detection

DNA Detection



By Applications

Pharmaceutical & Biotechnology Companies

Medical Device Companies

Research Institutes



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue

1.5 Market Analysis by Type

1.5.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Protein Detection

1.5.3 DNA Detection

1.6 Market by Application

1.6.1 Global Companion Diagnostic Tests in Oncology Market Share by Application: 2022-2027

1.6.2 Pharmaceutical & Biotechnology Companies

1.6.3 Medical Device Companies

1.6.4 Research Institutes

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Companion Diagnostic Tests in Oncology Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Companion Diagnostic Tests in Oncology Market Players Profiles

3.1 Abbott

3.1.1 Abbott Company Profile

3.1.2 Abbott Companion Diagnostic Tests in Oncology Product Specification

3.1.3 Abbott Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Roche

3.2.1 Roche Company Profile

3.2.2 Roche Companion Diagnostic Tests in Oncology Product Specification

3.2.3 Roche Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Genomic Health

3.3.1 Genomic Health Company Profile

3.3.2 Genomic Health Companion Diagnostic Tests in Oncology Product Specification

3.3.3 Genomic Health Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 QIAGEN

3.4.1 QIAGEN Company Profile

3.4.2 QIAGEN Companion Diagnostic Tests in Oncology Product Specification

3.4.3 QIAGEN Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Agilent

3.5.1 Agilent Company Profile

3.5.2 Agilent Companion Diagnostic Tests in Oncology Product Specification

3.5.3 Agilent Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Agendia

3.6.1 Agendia Company Profile

3.6.2 Agendia Companion Diagnostic Tests in Oncology Product Specification

3.6.3 Agendia Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 BioMerieux

3.7.1 BioMerieux Company Profile

3.7.2 BioMerieux Companion Diagnostic Tests in Oncology Product Specification

3.7.3 BioMerieux Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Illumina

3.8.1 Illumina Company Profile

3.8.2 Illumina Companion Diagnostic Tests in Oncology Product Specification

3.8.3 Illumina Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Siemens Healthcare

3.9.1 Siemens Healthcare Company Profile

3.9.2 Siemens Healthcare Companion Diagnostic Tests in Oncology Product Specification

3.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Thermo Fisher

3.10.1 Thermo Fisher Company Profile

3.10.2 Thermo Fisher Companion Diagnostic Tests in Oncology Product Specification

3.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Companion Diagnostic Tests in Oncology Market Competition by Market Players

4.1 Global Companion Diagnostic Tests in Oncology Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Market Players (2016-2021)

4.3 Global Companion Diagnostic Tests in Oncology Average Price by Market Players (2016-2021)

5 Global Companion Diagnostic Tests in Oncology Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Companion Diagnostic Tests in Oncology Market Size (2016-2021)

5.1.2 Companion Diagnostic Tests in Oncology Key Players in North America (2016-2021)

5.1.3 North America Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)

5.1.4 North America Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Companion Diagnostic Tests in Oncology Market Size (2016-2021)

5.2.2 Companion Diagnostic Tests in Oncology Key Players in East Asia (2016-2021)

5.2.3 East Asia Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)

5.2.4 East Asia Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Companion Diagnostic Tests in Oncology Market Size (2016-2021)

5.3.2 Companion Diagnostic Tests in Oncology Key Players in Europe (2016-2021)

5.3.3 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)

5.3.4 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Companion Diagnostic Tests in Oncology Market Size (2016-2021)

5.4.2 Companion Diagnostic Tests in Oncology Key Players in South Asia (2016-2021)

5.4.3 South Asia Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)

5.4.4 South Asia Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Companion Diagnostic Tests in Oncology Market Size (2016-2021)

5.5.2 Companion Diagnostic Tests in Oncology Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)

5.5.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Companion Diagnostic Tests in Oncology Market Size (2016-2021)

5.6.2 Companion Diagnostic Tests in Oncology Key Players in Middle East (2016-2021)

5.6.3 Middle East Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)

5.6.4 Middle East Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Companion Diagnostic Tests in Oncology Market Size (2016-2021)

5.7.2 Companion Diagnostic Tests in Oncology Key Players in Africa (2016-2021)

5.7.3 Africa Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)

5.7.4 Africa Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Companion Diagnostic Tests in Oncology Market Size (2016-2021)

5.8.2 Companion Diagnostic Tests in Oncology Key Players in Oceania (2016-2021)

5.8.3 Oceania Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)

5.8.4 Oceania Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Companion Diagnostic Tests in Oncology Market Size (2016-2021)

5.9.2 Companion Diagnostic Tests in Oncology Key Players in South America (2016-2021)

5.9.3 South America Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)

5.9.4 South America Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Companion Diagnostic Tests in Oncology Market Size (2016-2021)

5.10.2 Companion Diagnostic Tests in Oncology Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)

5.10.4 Rest of the World Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)

6 Global Companion Diagnostic Tests in Oncology Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Companion Diagnostic Tests in Oncology Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Companion Diagnostic Tests in Oncology Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Companion Diagnostic Tests in Oncology Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Companion Diagnostic Tests in Oncology Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Companion Diagnostic Tests in Oncology Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Companion Diagnostic Tests in Oncology Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Companion Diagnostic Tests in Oncology Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Companion Diagnostic Tests in Oncology Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Companion Diagnostic Tests in Oncology Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Companion Diagnostic Tests in Oncology Consumption by Countries

7 Global Companion Diagnostic Tests in Oncology Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Companion Diagnostic Tests in Oncology (2022-2027)

7.2 Global Forecasted Revenue of Companion Diagnostic Tests in Oncology (2022-2027)

7.3 Global Forecasted Price of Companion Diagnostic Tests in Oncology (2022-2027)

7.4 Global Forecasted Production of Companion Diagnostic Tests in Oncology by Region (2022-2027)

7.4.1 North America Companion Diagnostic Tests in Oncology Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Companion Diagnostic Tests in Oncology Production, Revenue Forecast (2022-2027)

7.4.3 Europe Companion Diagnostic Tests in Oncology Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Companion Diagnostic Tests in Oncology Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Companion Diagnostic Tests in Oncology Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Companion Diagnostic Tests in Oncology Production, Revenue Forecast (2022-2027)

7.4.7 Africa Companion Diagnostic Tests in Oncology Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Companion Diagnostic Tests in Oncology Production, Revenue Forecast (2022-2027)

7.4.9 South America Companion Diagnostic Tests in Oncology Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Companion Diagnostic Tests in Oncology Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Companion Diagnostic Tests in Oncology by Application (2022-2027)

8 Global Companion Diagnostic Tests in Oncology Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Companion Diagnostic Tests in Oncology by Country

8.2 East Asia Market Forecasted Consumption of Companion Diagnostic Tests in Oncology by Country

8.3 Europe Market Forecasted Consumption of Companion Diagnostic Tests in Oncology by Countriy

8.4 South Asia Forecasted Consumption of Companion Diagnostic Tests in Oncology by Country

8.5 Southeast Asia Forecasted Consumption of Companion Diagnostic Tests in Oncology by Country

8.6 Middle East Forecasted Consumption of Companion Diagnostic Tests in Oncology by Country

8.7 Africa Forecasted Consumption of Companion Diagnostic Tests in Oncology by Country

8.8 Oceania Forecasted Consumption of Companion Diagnostic Tests in Oncology by Country

8.9 South America Forecasted Consumption of Companion Diagnostic Tests in Oncology by Country

8.10 Rest of the world Forecasted Consumption of Companion Diagnostic Tests in Oncology by Country

9 Global Companion Diagnostic Tests in Oncology Sales by Type (2016-2027)

9.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Type (2016-2021)

9.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2022-2027)

10 Global Companion Diagnostic Tests in Oncology Consumption by Application (2016-2027)

10.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Application (2016-2021)

10.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2022-2027)

11 Global Companion Diagnostic Tests in Oncology Manufacturing Cost Analysis

11.1 Companion Diagnostic Tests in Oncology Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Companion Diagnostic Tests in Oncology

12 Global Companion Diagnostic Tests in Oncology Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Companion Diagnostic Tests in Oncology Distributors List

12.3 Companion Diagnostic Tests in Oncology Customers

12.4 Companion Diagnostic Tests in Oncology Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue (US$ Million) 2016-2021

Table 6. Global Companion Diagnostic Tests in Oncology Market Size by Type (US$ Million): 2022-2027

Table 7. Protein Detection Features

Table 8. DNA Detection Features

Table 16. Global Companion Diagnostic Tests in Oncology Market Size by Application (US$ Million): 2022-2027

Table 17. Pharmaceutical & Biotechnology Companies Case Studies

Table 18. Medical Device Companies Case Studies

Table 19. Research Institutes Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Companion Diagnostic Tests in Oncology Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Companion Diagnostic Tests in Oncology Market Growth Strategy

Table 46. Companion Diagnostic Tests in Oncology SWOT Analysis

Table 47. Abbott Companion Diagnostic Tests in Oncology Product Specification

Table 48. Abbott Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Roche Companion Diagnostic Tests in Oncology Product Specification

Table 50. Roche Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Genomic Health Companion Diagnostic Tests in Oncology Product Specification

Table 52. Genomic Health Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. QIAGEN Companion Diagnostic Tests in Oncology Product Specification

Table 54. Table QIAGEN Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Agilent Companion Diagnostic Tests in Oncology Product Specification

Table 56. Agilent Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Agendia Companion Diagnostic Tests in Oncology Product Specification

Table 58. Agendia Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. BioMerieux Companion Diagnostic Tests in Oncology Product Specification

Table 60. BioMerieux Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Illumina Companion Diagnostic Tests in Oncology Product Specification

Table 62. Illumina Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Siemens Healthcare Companion Diagnostic Tests in Oncology Product Specification

Table 64. Siemens Healthcare Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. Thermo Fisher Companion Diagnostic Tests in Oncology Product Specification

Table 66. Thermo Fisher Companion Diagnostic Tests in Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Companion Diagnostic Tests in Oncology Production Capacity by Market Players

Table 148. Global Companion Diagnostic Tests in Oncology Production by Market Players (2016-2021)

Table 149. Global Companion Diagnostic Tests in Oncology Production Market Share by Market Players (2016-2021)

Table 150. Global Companion Diagnostic Tests in Oncology Revenue by Market Players (2016-2021)

Table 151. Global Companion Diagnostic Tests in Oncology Revenue Share by Market Players (2016-2021)

Table 152. Global Market Companion Diagnostic Tests in Oncology Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Companion Diagnostic Tests in Oncology Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Companion Diagnostic Tests in Oncology Market Share (2016-2021)

Table 155. North America Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Companion Diagnostic Tests in Oncology Market Share by Type (2016-2021)

Table 157. North America Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Companion Diagnostic Tests in Oncology Market Share by Application (2016-2021)

Table 159. East Asia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Companion Diagnostic Tests in Oncology Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Companion Diagnostic Tests in Oncology Market Share (2016-2021)

Table 162. East Asia Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Companion Diagnostic Tests in Oncology Market Share by Type (2016-2021)

Table 164. East Asia Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Companion Diagnostic Tests in Oncology Market Share by Application (2016-2021)

Table 166. Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Companion Diagnostic Tests in Oncology Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Companion Diagnostic Tests in Oncology Market Share (2016-2021)

Table 169. Europe Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Companion Diagnostic Tests in Oncology Market Share by Type (2016-2021)

Table 171. Europe Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Companion Diagnostic Tests in Oncology Market Share by Application (2016-2021)

Table 173. South Asia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Companion Diagnostic Tests in Oncology Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Companion Diagnostic Tests in Oncology Market Share (2016-2021)

Table 176. South Asia Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Companion Diagnostic Tests in Oncology Market Share by Type (2016-2021)

Table 178. South Asia Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Companion Diagnostic Tests in Oncology Market Share by Application (2016-2021)

Table 180. Southeast Asia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Companion Diagnostic Tests in Oncology Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Companion Diagnostic Tests in Oncology Market Share (2016-2021)

Table 183. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Type (2016-2021)

Table 185. Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Application (2016-2021)

Table 187. Middle East Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Companion Diagnostic Tests in Oncology Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Companion Diagnostic Tests in Oncology Market Share (2016-2021)

Table 190. Middle East Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Companion Diagnostic Tests in Oncology Market Share by Type (2016-2021)

Table 192. Middle East Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Companion Diagnostic Tests in Oncology Market Share by Application (2016-2021)

Table 194. Africa Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Companion Diagnostic Tests in Oncology Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Companion Diagnostic Tests in Oncology Market Share (2016-2021)

Table 197. Africa Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Companion Diagnostic Tests in Oncology Market Share by Type (2016-2021)

Table 199. Africa Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Companion Diagnostic Tests in Oncology Market Share by Application (2016-2021)

Table 201. Oceania Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Companion Diagnostic Tests in Oncology Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Companion Diagnostic Tests in Oncology Market Share (2016-2021)

Table 204. Oceania Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Companion Diagnostic Tests in Oncology Market Share by Type (2016-2021)

Table 206. Oceania Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Companion Diagnostic Tests in Oncology Market Share by Application (2016-2021)

Table 208. South America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Companion Diagnostic Tests in Oncology Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Companion Diagnostic Tests in Oncology Market Share (2016-2021)

Table 211. South America Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Companion Diagnostic Tests in Oncology Market Share by Type (2016-2021)

Table 213. South America Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Companion Diagnostic Tests in Oncology Market Share by Application (2016-2021)

Table 215. Rest of the World Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Companion Diagnostic Tests in Oncology Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Companion Diagnostic Tests in Oncology Market Share (2016-2021)

Table 218. Rest of the World Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Companion Diagnostic Tests in Oncology Market Share by Type (2016-2021)

Table 220. Rest of the World Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Companion Diagnostic Tests in Oncology Market Share by Application (2016-2021)

Table 222. North America Companion Diagnostic Tests in Oncology Consumption by Countries (2016-2021)

Table 223. East Asia Companion Diagnostic Tests in Oncology Consumption by Countries (2016-2021)

Table 224. Europe Companion Diagnostic Tests in Oncology Consumption by Region (2016-2021)

Table 225. South Asia Companion Diagnostic Tests in Oncology Consumption by Countries (2016-2021)

Table 226. Southeast Asia Companion Diagnostic Tests in Oncology Consumption by Countries (2016-2021)

Table 227. Middle East Companion Diagnostic Tests in Oncology Consumption by Countries (2016-2021)

Table 228. Africa Companion Diagnostic Tests in Oncology Consumption by Countries (2016-2021)

Table 229. Oceania Companion Diagnostic Tests in Oncology Consumption by Countries (2016-2021)

Table 230. South America Companion Diagnostic Tests in Oncology Consumption by Countries (2016-2021)

Table 231. Rest of the World Companion Diagnostic Tests in Oncology Consumption by Countries (2016-2021)

Table 232. Global Companion Diagnostic Tests in Oncology Production Forecast by Region (2022-2027)

Table 233. Global Companion Diagnostic Tests in Oncology Sales Volume Forecast by Type (2022-2027)

Table 234. Global Companion Diagnostic Tests in Oncology Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Companion Diagnostic Tests in Oncology Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Companion Diagnostic Tests in Oncology Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Companion Diagnostic Tests in Oncology Sales Price Forecast by Type (2022-2027)

Table 238. Global Companion Diagnostic Tests in Oncology Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Companion Diagnostic Tests in Oncology Consumption Value Forecast by Application (2022-2027)

Table 240. North America Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027 by Country

Table 241. East Asia Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027 by Country

Table 242. Europe Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027 by Country

Table 243. South Asia Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027 by Country

Table 245. Middle East Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027 by Country

Table 246. Africa Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027 by Country

Table 247. Oceania Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027 by Country

Table 248. South America Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027 by Country

Table 250. Global Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2016-2021)

Table 252. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2022-2027)

Table 254. Global Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2016-2021)

Table 256. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2022-2027)

Table 258. Companion Diagnostic Tests in Oncology Distributors List

Table 259. Companion Diagnostic Tests in Oncology Customers List





Figure 1. Product Figure

Figure 2. Global Companion Diagnostic Tests in Oncology Market Share by Type: 2021 VS 2027

Figure 3. Global Companion Diagnostic Tests in Oncology Market Share by Application: 2021 VS 2027

Figure 4. North America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 6. North America Companion Diagnostic Tests in Oncology Consumption Market Share by Countries in 2021

Figure 7. United States Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 8. Canada Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Companion Diagnostic Tests in Oncology Consumption Market Share by Countries in 2021

Figure 12. China Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 13. Japan Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 15. Europe Companion Diagnostic Tests in Oncology Consumption and Growth Rate

Figure 16. Europe Companion Diagnostic Tests in Oncology Consumption Market Share by Region in 2021

Figure 17. Germany Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 19. France Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 20. Italy Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 21. Russia Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 22. Spain Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 25. Poland Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Companion Diagnostic Tests in Oncology Consumption and Growth Rate

Figure 27. South Asia Companion Diagnostic Tests in Oncology Consumption Market Share by Countries in 2021

Figure 28. India Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Companion Diagnostic Tests in Oncology Consumption and Growth Rate

Figure 30. Southeast Asia Companion Diagnostic Tests in Oncology Consumption Market Share by Countries in 2021

Figure 31. Indonesia Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Companion Diagnostic Tests in Oncology Consumption and Growth Rate

Figure 37. Middle East Companion Diagnostic Tests in Oncology Consumption Market Share by Countries in 2021

Figure 38. Turkey Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 40. Iran Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 42. Africa Companion Diagnostic Tests in Oncology Consumption and Growth Rate

Figure 43. Africa Companion Diagnostic Tests in Oncology Consumption Market Share by Countries in 2021

Figure 44. Nigeria Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Companion Diagnostic Tests in Oncology Consumption and Growth Rate

Figure 47. Oceania Companion Diagnostic Tests in Oncology Consumption Market Share by Countries in 2021

Figure 48. Australia Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 49. South America Companion Diagnostic Tests in Oncology Consumption and Growth Rate

Figure 50. South America Companion Diagnostic Tests in Oncology Consumption Market Share by Countries in 2021

Figure 51. Brazil Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Companion Diagnostic Tests in Oncology Consumption and Growth Rate

Figure 54. Rest of the World Companion Diagnostic Tests in Oncology Consumption Market Share by Countries in 2021

Figure 55. Global Companion Diagnostic Tests in Oncology Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Companion Diagnostic Tests in Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Companion Diagnostic Tests in Oncology Price and Trend Forecast (2022-2027)

Figure 58. North America Companion Diagnostic Tests in Oncology Production Growth Rate Forecast (2022-2027)

Figure 59. North America Companion Diagnostic Tests in Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Companion Diagnostic Tests in Oncology Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Companion Diagnostic Tests in Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Companion Diagnostic Tests in Oncology Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Companion Diagnostic Tests in Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Companion Diagnostic Tests in Oncology Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Companion Diagnostic Tests in Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Companion Diagnostic Tests in Oncology Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Companion Diagnostic Tests in Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Companion Diagnostic Tests in Oncology Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Companion Diagnostic Tests in Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Companion Diagnostic Tests in Oncology Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Companion Diagnostic Tests in Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Companion Diagnostic Tests in Oncology Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Companion Diagnostic Tests in Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Companion Diagnostic Tests in Oncology Production Growth Rate Forecast (2022-2027)

Figure 75. South America Companion Diagnostic Tests in Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Companion Diagnostic Tests in Oncology Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Companion Diagnostic Tests in Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027

Figure 79. East Asia Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027

Figure 80. Europe Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027

Figure 81. South Asia Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027

Figure 82. Southeast Asia Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027

Figure 83. Middle East Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027

Figure 84. Africa Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027

Figure 85. Oceania Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027

Figure 86. South America Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027

Figure 87. Rest of the world Companion Diagnostic Tests in Oncology Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Companion Diagnostic Tests in Oncology

Figure 89. Manufacturing Process Analysis of Companion Diagnostic Tests in Oncology

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Companion Diagnostic Tests in Oncology Supply Chain Analysis